Safety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial
Safety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial
Kazuhiro Yamamoto
1
, PhD
;
Takeshi Ioroi
1
, PhD
;
Kenichi Harada
2
, MD, PhD
;
Satoshi Nishiyama
3
, MD, PhD
;
Chikako Nishigori
3
, MD, PhD
;
Ikuko Yano
1
, PhD
1
Department of Pharmacy
,
Kobe University Hospital
,
Kobe
,
JP
2
Department of Urology
,
Graduate School of Medicine
,
Kobe University
,
Kobe
,
JP
3
Division of Dermatology, Department of Internal Related
,
Graduate School of Medicine
,
Kobe University
,
Kobe
,
JP